Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2020-08-03

Clinical Trial Update: Association Between Methotrexate Erythrocyte Polyglutamate Concentration and Clinical Response in Rheumatoid Arthritis Patients Treated With Subcutaneous Injectable Methotrexate [Phase 4]

View source ↗

Summary

Phase 4 clinical trial exploring the relationship between methotrexate erythrocyte polyglutamate levels and clinical response in rheumatoid arthritis patients t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Centre Hospitalier Universitaire de Saint Etienne | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED